首页> 外文期刊>Clinical and diagnostic laboratory immunology >Characterization of a monoclonal antibody specific for Brucella smooth lipopolysaccharide and development of a competitive enzyme-linked immunosorbent assay to improve the serological diagnosis of brucellosis.
【24h】

Characterization of a monoclonal antibody specific for Brucella smooth lipopolysaccharide and development of a competitive enzyme-linked immunosorbent assay to improve the serological diagnosis of brucellosis.

机译:特异于布鲁氏菌平滑脂多糖的单克隆抗体的表征和竞争性酶联免疫吸附测定的发展,以改善布鲁氏菌病的血清学诊断。

获取原文
           

摘要

The reactivity of monoclonal antibody (MAb) 12G12 was analyzed in regard to the main biovars of Brucella species and some members of the families Enterobacteriaceae and Vibrionaceae which present serological cross-reactions with the smooth lipopolysaccharide (S-LPS) of Brucella species. This MAb was strictly directed against the common specific epitope of the Brucella S-LPS. It recognized all of the smooth Brucella strains and biovars except B. suis biovar 2. In order to improve the specificity of the serological diagnosis of brucellosis, a competitive enzyme-linked immunosorbent assay (cELISA) was developed with the horseradish peroxidase-conjugated MAbs 12G12 and S-LPS of B. melitensis Rev1. The specificity of the cELISA was analyzed with 936 serum samples from healthy cattle. The assay was evaluated with sera from heifers (n = 18) experimentally infected with B. abortus 544. After infection, the performance of the cELISA was in agreement with those of the complement fixation test and the rose Bengal plate test. Finally, the specificity of the assay was also evaluated in regard to false-positive serological reactions by using sera from heifers experimentally infected with Yersinia enterocolitica 0:9 (n = 4) and with field sera presenting false-positive reactions (n = 74). The specificity of the cELISA was greater than the specificities of the complement fixation test and the rose Bengal plate test. Indeed, the new assay detected only 31 of the 101 false-positive serum samples detected by at least one serological test.
机译:针对布鲁氏菌属的主要生物变种以及肠杆菌科和弧菌科的一些成员,分析了单克隆抗体(MAb)12G12的反应性,这些细菌与布鲁氏菌属的平滑脂多糖(S-LPS)发生了血清学交叉反应。该单克隆抗体严格针对布鲁氏菌S-LPS的常见特异性表位。它识别了除了B. suis biovar 2以外的所有光滑布鲁氏菌菌株和生物变种。为了提高布鲁氏菌病血清学诊断的特异性,开发了一种竞争性酶联免疫吸附测定(cELISA),其使用了辣根过氧化物酶结合的单克隆抗体12G12。 B. melitensis Rev1和S-LPS。用936头健康牛的血清样品分析了cELISA的特异性。用实验感染流产双歧杆菌544的小母牛血清(n = 18)评估该测定。感染后,cELISA的性能与补体固定试验和玫瑰孟加拉平板试验一致。最后,还通过使用实验性感染小肠结肠炎耶尔森氏菌0:9(n = 4)的小母牛血清和出现假阳性反应的野外血清(n = 74)对假阳性血清学反应的测定特异性进行了评估。 。 cELISA的特异性大于补体固定试验和玫瑰孟加拉平板试验的特异性。实际上,新的检测方法仅通过至少一项血清学检测检测到101个假阳性血清样品中仅检测到31个。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号